Macrophages: Their Emerging Roles in Bone

Journal of Bone and Mineral Research

Volumn 30, Issue 12, 2015, Pages 2140-2149

  Sinder, Benjamin P ^a   Pettit, Allison R ^b   McCauley, Laurie K ^a,c  

^a UNIVERSITY OF MICHIGAN SCHOOL OF DENTISTRY   (United States)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

BONE FORMATION; EFFEROCYTOSIS; FRACTURE REPAIR; MACROPHAGE; SKELETAL METASTASIS

Indexed keywords

APOPTOSIS; BONE DEVELOPMENT; BONE MARROW CELL; BONE METASTASIS; BONE REGENERATION; BONE REMODELING; FRACTURE HEALING; HOMEOSTASIS; HUMAN; IN VIVO STUDY; MACROPHAGE; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; PHAGOCYTOSIS; PHENOTYPE; PRIMARY TUMOR; REVIEW; STEM CELL; WOUND HEALING; ANIMAL; BONE; C57BL MOUSE; CYTOLOGY; IMMUNE SYSTEM; IMMUNOHISTOCHEMISTRY; METABOLISM; MOUSE; PHYSIOLOGY;

ANIMALS; APOPTOSIS; BONE AND BONES; FRACTURE HEALING; HOMEOSTASIS; HUMANS; IMMUNE SYSTEM; IMMUNOHISTOCHEMISTRY; MACROPHAGES; MICE; MICE, INBRED C57BL; OSTEOBLASTS; PHAGOCYTOSIS; PHENOTYPE; WOUND HEALING;

EID: 84954044728     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.2735     Document Type: Review

References (108)

1. Biswas SK, Mantovani A., Orchestration of metabolism by macrophages. Cell Metab. 2012; 15 (4): 432-7.
2. Davies LC, Jenkins SJ, Allen JE, Taylor PR., Tissue-resident macrophages. Nat Immunol. 2013; 14 (10): 986-95.
3. Chang MK, Raggatt L-J, Alexander KA, et al., Osteal tissue macrophages are intercalated throughout human and mouse bone lining tissues and regulate osteoblast function in vitro and in vivo. J Immunol. 2008; 181 (2): 1232-44.
4. Hume DA, Loutit JF, Gordon S., The mononuclear phagocyte system of the mouse defined by immunohistochemical localization of antigen F4/80: macrophages of bone and associated connective tissue. J Cell Sci. 1984; 66: 189-94.
5. Wu AC, Raggatt LJ, Alexander KA, Pettit AR., Unraveling macrophage contributions to bone repair. Bonekey Rep. 2013; 2: 373.
6. Nicolaidou V, Wong MM, Redpath AN, et al., Monocytes induce STAT3 activation in human mesenchymal stem cells to promote osteoblast formation. PLoS One. 2012; 7 (7): e39871.
7. Guihard P, Danger Y, Brounais B, et al., Induction of osteogenesis in mesenchymal stem cells by activated monocytes/macrophages depends on oncostatin M signaling. Stem Cells. 2012; 30 (4): 762-72.
8. Shioi A, Katagi M, Okuno Y, et al., Induction of bone-type alkaline phosphatase in human vascular smooth muscle cells: roles of tumor necrosis factor-alpha and oncostatin M derived from macrophages. Circ Res. 2002; 91 (1): 9-16.
9. Tintut Y, Patel J, Territo M, Saini T, Parhami F, Demer LL., Monocyte/macrophage regulation of vascular calcification in vitro. Circulation. 2002; 105 (5): 650-5.
10. Burnett SH, Kershen EJ, Zhang J, et al., Conditional macrophage ablation in transgenic mice expressing a Fas-based suicide gene. J Leukoc Biol. 2004; 75 (4): 612-23.
11. Burnett SH, Beus BJ, Avdiushko R, Qualls J, Kaplan AM, Cohen DA., Development of peritoneal adhesions in macrophage depleted mice. J Surg Res. 2006; 131 (2): 296-301.
12. Winkler IG, Sims NA, Pettit AR, et al., Bone marrow macrophages maintain hematopoietic stem cell (HSC) niches and their depletion mobilizes HSCs. Blood. 2010; 116 (23): 4815-28.
13. Christopher MJ, Rao M, Liu F, Woloszynek JR, Link DC., Expression of the G-CSF receptor in monocytic cells is sufficient to mediate hematopoietic progenitor mobilization by G-CSF in mice. J Exp Med. 2011; 208 (2): 251-60.
14. Winkler IG, Pettit AR, Raggatt LJ, et al., Hematopoietic stem cell mobilizing agents G-CSF, cyclophosphamide or AMD3100 have distinct mechanisms of action on bone marrow HSC niches and bone formation. Leukemia. 2012; 26 (7): 1594-601.
15. Jacobsen RN, Forristal CE, Raggatt LJ, et al., Mobilization with granulocyte colony-stimulating factor blocks medullar erythropoiesis by depleting F4/80+VCAM1+CD169+ER-HR3+Ly6G+ erythroid island macrophages in the mouse. Exp Hematol. 2014; 42 (7): 547-61.e4.
16. Cho SW, Soki FN, Koh AJ, et al., Osteal macrophages support physiologic skeletal remodeling and anabolic actions of parathyroid hormone in bone. Proc Natl Acad Sci U S A. 2014; 111 (4): 1545-50.
17. Vi L, Baht GS, Whetstone H, et al., Macrophages promote osteoblastic differentiation in-vivo: implications in fracture repair and bone homeostasis. J Bone Miner Res. 2015; 30 (6): 1090-102.
18. Lloyd SA, Yuan YY, Simske SJ, Riffle SE, Ferguson VL, Bateman TA., Administration of high-dose macrophage colony-stimulating factor increases bone turnover and trabecular volume fraction. J Bone Miner Metab. 2009; 27 (5): 546-54.
19. Gow DJ, Sauter KA, Pridans C, et al., Characterisation of a novel Fc conjugate of macrophage colony-stimulating factor. Mol Ther J Am Soc Gene Ther. 2014; 22 (9): 1580-92.
20. Garceau V, Balic A, Garcia-Morales C, et al., The development and maintenance of the mononuclear phagocyte system of the chick is controlled by signals from the macrophage colony-stimulating factor receptor. BMC Biol. 2015; 13: 12.
21. Pape H-C, Marcucio R, Humphrey C, Colnot C, Knobe M, Harvey EJ., Trauma-induced inflammation and fracture healing. J Orthop Trauma. 2010; 24 (9): 522-5.
22. Schindeler A, McDonald MM, Bokko P, Little DG., Bone remodeling during fracture repair: the cellular picture. Semin Cell Dev Biol. 2008; 19 (5): 459-66.
23. Xing Z, Lu C, Hu D, et al., Multiple roles for CCR2 during fracture healing. Dis Model Mech. 2010; 3 (7-8): 451-8.
24. Alexander KA, Chang MK, Maylin ER, et al., Osteal macrophages promote in vivo intramembranous bone healing in a mouse tibial injury model. J Bone Miner Res. 2011; 26 (7): 1517-32.
25. Raggatt LJ, Wullschleger ME, Alexander KA, et al., Fracture healing via periosteal callus formation requires macrophages for both initiation and progression of early endochondral ossification. Am J Pathol. 2014; 184 (12): 3192-204.
26. McDonald MM, Dulai S, Godfrey C, Amanat N, Sztynda T, Little DG., Bolus or weekly zoledronic acid administration does not delay endochondral fracture repair but weekly dosing enhances delays in hard callus remodeling. Bone. 2008; 43 (4): 653-62.
27. Petrie TA, Strand NS, Tsung-Yang C, Rabinowitz JS, Moon RT., Macrophages modulate adult zebrafish tail fin regeneration. Development. 2014; 141 (13): 2581-91.
28. Novak ML, Koh TJ., Phenotypic transitions of macrophages orchestrate tissue repair. Am J Pathol. 2013; 183 (5): 1352-63.
29. Andrew JG, Andrew SM, Freemont AJ, Marsh DR,. Inflammatory cells in normal human fracture healing. Acta Orthop Scand. 1994; 65 (4): 462-6.
30. Wang X, Yu YY, Lieu S, et al., MMP9 regulates the cellular response to inflammation after skeletal injury. Bone. 2013; 52 (1): 111-9.
31. Forbes SJ, Rosenthal N., Preparing the ground for tissue regeneration: from mechanism to therapy. Nat Med. 2014; 20 (8): 857-69.
32. Guihard P, Boutet M-A, Brounais-Le Royer B, et al., Oncostatin M, an inflammatory cytokine produced by macrophages, supports intramembranous bone healing in a mouse model of tibia injury. Am J Pathol. 2015; 185 (3): 765-75.
33. Muller PA, Koscsõ B, Rajani GM, et al., Crosstalk between muscularis macrophages and enteric neurons regulates gastrointestinal motility. Cell. 2014; 158 (2): 300-13.
34. Kan L, Liu Y, McGuire TL, et al., Dysregulation of local stem/progenitor cells as a common cellular mechanism for heterotopic ossification. Stem Cells. 2009; 27 (1): 150-6.
35. Fernandes TJ, Hodge JM, Singh PP, et al., Cord blood-derived macrophage-lineage cells rapidly stimulate osteoblastic maturation in mesenchymal stem cells in a glycoprotein-130 dependent manner. PLoS One. 2013; 8 (9): e73266.
36. Lyons FG, Al-Munajjed AA, Kieran SM, et al., The healing of bony defects by cell-free collagen-based scaffolds compared to stem cell-seeded tissue engineered constructs. Biomaterials. 2010; 31 (35): 9232-43.
37. Pirraco RP, Reis RL, Marques AP., Effect of monocytes/macrophages on the early osteogenic differentiation of hBMSCs. J Tissue Eng Regen Med. 2013; 7 (5): 392-400.
38. Hankemeier S, Grässel S, Plenz G, Spiegel HU, Bruckner P, Probst A., Alteration of fracture stability influences chondrogenesis, osteogenesis and immigration of macrophages. J Orthop Res. 2001; 19 (4): 531-8.
39. Asada N, Katayama Y, Sato M, et al., Matrix-embedded osteocytes regulate mobilization of hematopoietic stem/progenitor cells. Cell Stem Cell. 2013; 12 (6): 737-47.
40. Gruber R, Koch H, Doll BA, Tegtmeier F, Einhorn TA, Hollinger JO., Fracture healing in the elderly patient. Exp Gerontol. 2006; 41 (11): 1080-93.
41. Lopas LA, Belkin NS, Mutyaba PL, Gray CF, Hankenson KD, Ahn J., Fractures in geriatric mice show decreased callus expansion and bone volume. Clin Orthop. 2014; 472 (11): 3523-32.
42. Xing Z, Lu C, Hu D, Miclau T, Marcucio RS., Rejuvenation of the inflammatory system stimulates fracture repair in aged mice. J Orthop Res. 2010; 28 (8): 1000-6.
43. Baht GS, Silkstone D, Vi L, et al., Exposure to a youthful circulation rejuvenates bone repair through modulation of β-catenin. Nat Commun. 2015; 6: 7131.
44. Hume DA, MacDonald KPA., Therapeutic applications of macrophage colony-stimulating factor-1 (CSF-1) and antagonists of CSF-1 receptor (CSF-1R) signaling. Blood. 2012; 119 (8): 1810-20.
45. Sarahrudi K, Mousavi M, Grossschmidt K, et al., The impact of colony-stimulating factor-1 on fracture healing: an experimental study. J Orthop Res. 2009; 27 (1): 36-41.
46. MacDonald KPA, Palmer JS, Cronau S, et al., An antibody against the colony-stimulating factor 1 receptor depletes the resident subset of monocytes and tissue- and tumor-associated macrophages but does not inhibit inflammation. Blood. 2010; 116 (19): 3955-63.
47. Nikolaou VS, Efstathopoulos N, Kontakis G, Kanakaris NK, Giannoudis PV., The influence of osteoporosis in femoral fracture healing time. Injury. 2009; 40 (6): 663-8.
48. Hernandez RK, Do TP, Critchlow CW, Dent RE, Jick SS., Patient-related risk factors for fracture-healing complications in the United Kingdom General Practice Research Database. Acta Orthop. 2012; 83 (6): 653-60.
49. Schipper LG, Fleuren HWHA, van den Bergh JPW, Meinardi JR, Veldman BAJ, Kramers C., Treatment of osteoporosis in renal insufficiency. Clin Rheumatol. 2015; 34 (8): 1341-5.
50. Green E, Lubahn JD, Evans J., Risk factors, treatment, and outcomes associated with nonunion of the midshaft humerus fracture. J Surg Orthop Adv. 2005; 14 (2): 64-72.
51. McLean RR., Proinflammatory cytokines and osteoporosis. Curr Osteoporos Rep. 2009; 7 (4): 134-9.
52. Reikerås O, Shegarfi H, Wang JE, Utvåg SE., Lipopolysaccharide impairs fracture healing: an experimental study in rats. Acta Orthop. 2005; 76 (6): 749-53.
53. Reikerås O, Wang JE, Foster SJ, Utvåg SE., Staphylococcus aureus peptidoglycan impairs fracture healing: an experimental study in rats. J Orthop Res. 2007; 25 (2): 262-6.
54. Simon AM, O'Connor JP., Dose and time-dependent effects of cyclooxygenase-2 inhibition on fracture-healing. J Bone Joint Surg Am. 2007; 89 (3): 500-11.
55. Slade Shantz JA, Yu Y-Y, Andres W, Miclau T, Marcucio R., Modulation of macrophage activity during fracture repair has differential effects in young adult and elderly mice. J Orthop Trauma. 2014; 28 Suppl 1: S10-4.
56. Muñoz LE, Lauber K, Schiller M, Manfredi AA, Herrmann M., The role of defective clearance of apoptotic cells in systemic autoimmunity. Nat Rev Rheumatol. 2010; 6 (5): 280-9.
57. Baumann I, Kolowos W, Voll RE, et al., Impaired uptake of apoptotic cells into tingible body macrophages in germinal centers of patients with systemic lupus erythematosus. Arthritis Rheum. 2002; 46 (1): 191-201.
58. Shao W-H, Cohen PL., Disturbances of apoptotic cell clearance in systemic lupus erythematosus. Arthritis Res Ther. 2011; 13 (1): 202.
59. Poon IKH, Lucas CD, Rossi AG, Ravichandran KS., Apoptotic cell clearance: basic biology and therapeutic potential. Nat Rev Immunol. 2014; 14 (3): 166-80.
60. Hochreiter-Hufford A, Ravichandran KS., Clearing the dead: apoptotic cell sensing, recognition, engulfment, and digestion. Cold Spring Harb Perspect Biol. 2013; 5 (1): a008748.
61. Ravichandran KS., Find-me and eat-me signals in apoptotic cell clearance: progress and conundrums. J Exp Med. 2010; 207 (9): 1807-17.
62. Martin CJ, Peters KN, Behar SM., Macrophages clean up: efferocytosis and microbial control. Curr Opin Microbiol. 2014; 17: 17-23.
63. Hotchkiss RS, Strasser A, McDunn JE, Swanson PE., Cell death in disease: mechanisms and emerging therapeutic concepts. N Engl J Med. 2009; 361 (16): 1570-83.
64. Melino G., The sirens' song. Nature. 2001; 412 (6842): 23.
65. Thorp E, Tabas I., Mechanisms and consequences of efferocytosis in advanced atherosclerosis. J Leukoc Biol. 2009; 86 (5): 1089-95.
66. Van Rooijen N, Sanders A., Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. J Immunol Methods. 1994; 174 (1-2): 83-93.
67. Lin S-L, Li B, Rao S, et al., Macrophage Wnt7b is critical for kidney repair and regeneration. Proc Natl Acad Sci U S A. 2010; 107 (9): 4194-9.
68. Boulter L, Govaere O, Bird TG, et al., Macrophage-derived Wnt opposes Notch signaling to specify hepatic progenitor cell fate in chronic liver disease. Nat Med. 2012; 18 (4): 572-9.
69. Pederson L, Ruan M, Westendorf JJ, Khosla S, Oursler MJ., Regulation of bone formation by osteoclasts involves Wnt/BMP signaling and the chemokine sphingosine-1-phosphate. Proc Natl Acad Sci U S A. 2008; 105 (52): 20764-9.
70. Terauchi M, Li J-Y, Bedi B, et al., T lymphocytes amplify the anabolic activity of parathyroid hormone through Wnt10b signaling. Cell Metab. 2009; 10 (3): 229-40.
71. Li J-Y, Walker LD, Tyagi AM, Adams J, Weitzmann MN, Pacifici R., The sclerostin-independent bone anabolic activity of intermittent PTH treatment is mediated by T-cell-produced Wnt10b. J Bone Miner Res. 2014; 29 (1): 43-54.
72. Ogawa K, Yoshioka Y, Isohashi F, Seo Y, Yoshida K, Yamazaki H., Radiotherapy targeting cancer stem cells: current views and future perspectives. Anticancer Res. 2013; 33 (3): 747-54.
73. Koh AJ, Novince CM, Li X, Wang T, Taichman RS, McCauley LK., An irradiation-altered bone marrow microenvironment impacts anabolic actions of PTH. Endocrinology. 2011; 152 (12): 4525-36.
74. Quach JM, Askmyr M, Jovic T, et al., Myelosuppressive therapies significantly increase pro-inflammatory cytokines and directly cause bone loss. J Bone Miner Res. 2015; 30 (5): 886-97.
75. Zhang Q, Miller C, Bible J, et al., Additive effects of mechanical marrow ablation and PTH treatment on de novo bone formation in mature adult rats. Cells. 2012; 1 (4): 1168-81.
76. Parfitt AM., Bone-forming cells in clinical conditions. In:, Hall B, editor. Bone. Vol 1. Osteoblast osteocyte. Boca Raton, FL: CRC Press; 1990. p. 351-429.
77. Jilka RL, Weinstein RS, Bellido T, Parfitt AM, Manolagas SC., Osteoblast programmed cell death (apoptosis): modulation by growth factors and cytokines. J Bone Miner Res. 1998; 13 (5): 793-802.
78. Tang Y, Wu X, Lei W, et al., TGF-beta1-induced migration of bone mesenchymal stem cells couples bone resorption with formation. Nat Med. 2009; 15 (7): 757-65.
79. Wu X, Pang L, Lei W, et al., Inhibition of Sca-1-positive skeletal stem cell recruitment by alendronate blunts the anabolic effects of parathyroid hormone on bone remodeling. Cell Stem Cell. 2010; 7 (5): 571-80.
80. Xian L, Wu X, Pang L, et al., Matrix IGF-1 regulates bone mass by activation of mTOR in mesenchymal stem cells. Nat Med. 2012; 18 (7): 1095-101.
81. Lotinun S, Kiviranta R, Matsubara T, et al., Osteoclast-specific cathepsin K deletion stimulates S1P-dependent bone formation. J Clin Invest. 2013; 123 (2): 666-81.
82. Takeshita S, Fumoto T, Matsuoka K, et al., Osteoclast-secreted CTHRC1 in the coupling of bone resorption to formation. J Clin Invest. 2013; 123 (9): 3914-24.
83. Xiao YQ, Freire-de-Lima CG, Schiemann WP, Bratton DL, Vandivier RW, Henson PM., Transcriptional and translational regulation of TGF-β production in response to apoptotic cells. J Immunol. 2008; 181 (5): 3575-85.
84. McCauley LK, Dalli J, Koh AJ, Chiang N, Serhan CN., Cutting edge: parathyroid hormone facilitates macrophage efferocytosis in bone marrow via proresolving mediators resolvin D1 and resolvin D2. J Immunol. 2014; 193 (1): 26-9.
85. Cho SW, Pirih FQ, Koh AJ, et al., The soluble interleukin-6 receptor is a mediator of hematopoietic and skeletal actions of parathyroid hormone. J Biol Chem. 2013; 288 (10): 6814-25.
86. Weilbaecher KN, Guise TA, McCauley LK., Cancer to bone: a fatal attraction. Nat Rev Cancer. 2011; 11 (6): 411-25.
87. Guise TA, Mundy GR., Cancer and bone. Endocr Rev. 1998; 19 (1): 18-54.
88. Pollard JW., Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer. 2004; 4 (1): 71-8.
89. Roca H, Varsos ZS, Sud S, Craig MJ, Ying C, Pienta KJ., CCL2 and interleukin-6 promote survival of human CD11b+ peripheral blood mononuclear cells and induce M2-type macrophage polarization. J Biol Chem. 2009; 284 (49): 34342-54.
90. Soki FN, Cho SW, Kim YW, et al., Bone marrow macrophages support prostate cancer growth in bone. Oncotarget. Forthcoming. Epub 2015 Oct 8. DOI: 10.18632/oncotarget.6042.
91. Li X, Loberg R, Liao J, et al., A destructive cascade mediated by CCL2 facilitates prostate cancer growth in bone. Cancer Res. 2009; 69 (4): 1685-92.
92. Steiner JL, Murphy EA., Importance of chemokine (CC-motif) ligand 2 in breast cancer. Int J Biol Markers. 2012; 27 (3): e179-85.
93. Lindholm PF, Lu Y, Adley BP, et al., Role of monocyte-lineage cells in prostate cancer cell invasion and tissue factor expression. Prostate. 2010; 70 (15): 1672-82.
94. Tang X., Tumor-associated macrophages as potential diagnostic and prognostic biomarkers in breast cancer. Cancer Lett. 2013; 332 (1): 3-10.
95. Polverini PJ, Leibovich SJ., Induction of neovascularization in vivo and endothelial proliferation in vitro by tumor-associated macrophages. Lab Invest. 1984; 51 (6): 635-42.
96. Laurent J, Touvrey C, Botta F, Kuonen F, Ruegg C., Emerging paradigms and questions on pro-angiogenic bone marrow-derived myelomonocytic cells. Int J Dev Biol. 2011; 55 (4-5): 527-34.
97. Park SI, Liao J, Berry JE, et al., Cyclophosphamide creates a receptive microenvironment for prostate cancer skeletal metastasis. Cancer Res. 2012; 72 (10): 2522-32.
98. Sullivan AR, Pixley FJ., CSF-1R signaling in health and disease: a focus on the mammary gland. J Mammary Gland Biol Neoplasia. 2014; 19 (2): 149-59.
99. Soki FN, Koh AJ, Jones JD, et al., Polarization of prostate cancer-associated macrophages is induced by milk fat globule-EGF factor 8 (MFG-E8)-mediated efferocytosis. J Biol Chem. 2014; 289 (35): 24560-72.
100. Stockschlaeder M, Sucker C., Adult Langerhans cell histiocytosis. Eur J Haematol. 2006; 76 (5): 363-8.
101. Kamizono J, Okada Y, Shirahata A, Tanaka Y., Bisphosphonate induces remission of refractory osteolysis in Langerhans cell histiocytosis. J Bone Miner Res. 2002; 17 (11): 1926-8.
102. Mazor RD, Manevich-Mazor M, Shoenfeld Y., Erdheim-Chester disease: a comprehensive review of the literature. Orphanet J Rare Dis. 2013; 8: 137.
103. Resnick D, Greenway G, Genant H, Brower A, Haghighi P, Emmett M., Erdheim-Chester disease. Radiology. 1982; 142 (2): 289-95.
104. Foucar E, Rosai J, Dorfman R., Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): review of the entity. Semin Diagn Pathol. 1990; 7 (1): 19-73.
105. Demicco EG, Rosenberg AE, Björnsson J, Rybak LD, Unni KK, Nielsen GP., Primary Rosai-Dorfman disease of bone: a clinicopathologic study of 15 cases. Am J Surg Pathol. 2010; 34 (9): 1324-33.
106. Geissmann F, Lepelletier Y, Fraitag S, et al., Differentiation of Langerhans cells in Langerhans cell histiocytosis. Blood. 2001; 97 (5): 1241-8.
107. Pulsoni A, Anghel G, Falcucci P, et al., Treatment of sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): report of a case and literature review. Am J Hematol. 2002; 69 (1): 67-71.
108. Rizzo FM, Cives M, Simone V, Silvestris F., New insights into the molecular pathogenesis of Langerhans cell histiocytosis. Oncologist. 2014; 19 (2): 151-63.